investordatabase.org

Sofinnova Investments, INC.

sofinnova.com Direct investor

Sofinnova is a healthcare investment firm founded in 1976, focusing on life science investing, primarily in therapeutic drugs. It invests in private and public equity companies, with approximately $4.6B in assets under management.

Sofinnova Investments, INC. is a venture capital firm headquartered in Menlo Park, United States, founded in 1976. It invests directly in companies, from Series A to growth, in therapeutics, biotech and life sciences. $4.6B under management and 120 portfolio companies, as it reports.

“Sofinnova invests in late preclinical and clinical therapeutic companies across the U.S. and Europe.”

— Sofinnova Investments, INC., own website
Layer
Direct investor
Type
Venture capital
Stage
Series A – Growth
Headquarters
Menlo Park, United States
Invests in
US, Europe
Sectors
therapeutics, biotech, life sciences
Founded
1976
Assets under management
$4.6B
Portfolio
120 companies

Team, as Sofinnova Investments, INC. publishes it

  • Jim Healy Managing Partner
  • Maha Katabi General Partner
  • David Kabakoff Executive Advisor, Private Equity
  • Lars Ekman Executive Partner, Private Equity
  • Perry Nisen Executive Advisor, Private Equity
  • Jonathan Leff Executive Partner, Private Equity
  • Chris Carpenter Executive Partner, Private Equity
  • Jakob Dupont Executive Partner, Private Equity
  • Maha Radhakrishnan Executive Partner, Private Equity
  • Troy Ignelzi Executive Advisor, Private Equity
  • Mike Van Associate, Private Equity
  • Naomi Pacalin Associate, Private Equity

Names and roles exactly as listed on sofinnova.com. Nothing else about these people is recorded.

Co-invests most often with

Derived from portfolio pages both investors publish themselves: each pair below lists at least one company in common. 73 co-investors found.

  • RA Capital Management 12 shared companies: ascendispharma.com, bioagelabs.com, aclaristx.com, coherus.com…
  • Avoro Capital Advisors LLC 7 shared companies: ascendispharma.com, apellis.com, merus.nl, amarincorp.com…
  • Aisling Capital Management LP 5 shared companies: ascendispharma.com, obseva.com, aclaristx.com, audentestx.com…
  • Foresite Capital 5 shared companies: ascendispharma.com, arrivent.com, aclaristx.com, audentestx.com…
  • Sofinnova 5 shared companies: ascendispharma.com, cincor.com, nucana.com, obseva.com…
  • Longitude Capital 5 shared companies: bioagelabs.com, inozyme.com, amarincorp.com, checkmatepharma.com…
  • OrbiMed 5 shared companies: bioagelabs.com, arrivent.com, star-therapeutics.com, avenzotx.com…
  • ARCH Venture Partners 5 shared companies: karunatx.com, mallinckrodt.com, citytx.com, rapportrx.com…
  • venBio Partners LLC 4 shared companies: apellis.com, aeovian.com, mareatx.com, rayzebio.com
  • Viking Global Investors LP 4 shared companies: star-therapeutics.com, rayzebio.com, atyrpharma.com, velosbio.com

and 63 more — the graph.

Where this comes from

Every fact above was read from a page Sofinnova Investments, INC. publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.

Record 4502 · added 2026-09-03 · link last verified 2026-09-06 · confidence high

Similar investors

Listed under